H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009
- Sponsor:
- Robert Berry
- Summary:
- To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. (by CRS)
- Status:
- The bill has been introduced.
Pharmaceutical Market Access and Drug Safety Act of 2009
H.R. 1298 — 111th Congress (2009–2010)
- Summary
- To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
- Other Titles
- Pharmaceutical Market Access and Drug Safety Act of 2009
- Sponsor
- Robert Berry
- Co-Sponsors
- Timothy Bishop
- Barton Gordon
- John Tierney
- Michael Simpson
- Michael Arcuri
- Christopher Carney
- Robert Goodlatte
- John Duncan
- Gary Ackerman
- James Marshall
- Dan Burton
- Tom McClintock
- Dale Kildee
- Steven LaTourette
- Rodney Alexander
- Roscoe Bartlett
- Nick Rahall
- Jerry Costello
- Jo Ann Emerson
- Harry Mitchell
- Ronald Paul
- Jane Harman
- Gene Taylor
- Lynn Woolsey
- Steve Kagen
- Janice Schakowsky
- Marcy Kaptur
- Christopher Van Hollen
- Doc Hastings
- Betty Sutton
- Thomas Petri
- John Murtha
- Peter Hoekstra
- Carol Shea-Porter
- Todd Platts
- Peter DeFazio
- Frank Wolf
- Subjects
- Health
- Administrative law and regulatory procedures
- Administrative remedies
- Asia
- Australia
- Business records
- Canada
- Civil actions and liability
- Consumer affairs
- Consumer credit
- Contracts and agency
- Department of Health and Human Services
- Europe
- European Union
- Evidence and witnesses
- Federal Trade Commission (FTC)
- Federal preemption
- Food and Drug Administration (FDA)
- Fraud offenses and financial crimes
- Government investigations
- Health information and medical records
- Intellectual property
- Intergovernmental relations
- Internet and video services
- Japan
- Marketing and advertising
- Medical education
- Medical tests and diagnostic methods
- New Zealand
- Oceania
- Prescription drugs
- Product safety and quality
- Retail and wholesale trades
- Switzerland
- Trade restrictions
- User charges and fees
- Related Bills
- Major Actions
Introduced 3/04/2009 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 3/04/2009 3/04/2009 Referred to the House Committee on Energy and Commerce. 3/05/2009 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
MapLight did not identify any interest groups that took a position on this vote.
You may be able to explore campaign contributions data if you add interest groups.
Help your colleagues by suggesting an organization that took a position on this vote.
Contributions data source: OpenSecrets.org
